| 14.695 0.495 (3.49%) | 09-02 13:58 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 17.21 |
1-year : | 20.1 |
| Resists | First : | 14.73 |
Second : | 17.21 |
| Pivot price | 14.18 |
|||
| Supports | First : | 13.71 |
Second : | 13.07 |
| MAs | MA(5) : | 14.51 |
MA(20) : | 14.04 |
| MA(100) : | 10.48 |
MA(250) : | 10.86 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 81.2 |
D(3) : | 84.5 |
| RSI | RSI(14): 65.9 |
|||
| 52-week | High : | 15.93 | Low : | 7.26 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AVTR ] has closed below upper band by 23.1%. Bollinger Bands are 7.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.67 - 14.75 | 14.75 - 14.82 |
| Low: | 13.98 - 14.1 | 14.1 - 14.18 |
| Close: | 14.05 - 14.22 | 14.22 - 14.34 |
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Tue, 01 Sep 2026
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Mon, 31 Aug 2026
Avantor, Inc. (AVTR) Stock Analysis: Evaluating Its Modest Growth Potential Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Fri, 28 Aug 2026
Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report? - Yahoo Finance
Thu, 20 Aug 2026
Avantor (NYSE: AVTR) CEO keeps 737,334 shares after RSU tax withholding - Stock Titan
Wed, 19 Aug 2026
Is Avantor (AVTR) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Wed, 29 Jul 2026
Avantor, Inc. (AVTR) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 676 (M) |
| Shares Float | 658 (M) |
| Held by Insiders | 1.5 (%) |
| Held by Institutions | 105.3 (%) |
| Shares Short | 53,170 (K) |
| Shares Short P.Month | 51,960 (K) |
| EPS | -0.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.31 |
| Profit Margin | -8.9 % |
| Operating Margin | 7.1 % |
| Return on Assets (ttm) | 2.6 % |
| Return on Equity (ttm) | -9.7 % |
| Qtrly Rev. Growth | 0.5 % |
| Gross Profit (p.s.) | 3.09 |
| Sales Per Share | 9.69 |
| EBITDA (p.s.) | 1.39 |
| Qtrly Earnings Growth | -37.5 % |
| Operating Cash Flow | 597 (M) |
| Levered Free Cash Flow | 450 (M) |
| PE Ratio | -17.21 |
| PEG Ratio | 0 |
| Price to Book value | 1.75 |
| Price to Sales | 1.5 |
| Price to Cash Flow | 16.56 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|